The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Conditions

• The Neoadjuvant Therapy

Interventions

• DRUG: Ribocyclib, fulvestrant, triptorelin
• DRUG: Doxorubicin, cyclophosphamide, paclitaxel

Sponsor

Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary